Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heat therapy plus topical liposomal amphotericin B for cutaneous leishmaniasis (Leishmania major)
IRCT201510031475N8Phase 3Completed
- Sponsor
- NIMAD
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of amphotericin b in cutaneous leishmaniasis (CL), sponsored by NIMAD. Started Dec 2016; status: completed.
02
Drugs
amphotericin b
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on IRCT201510031475N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201510031475N8.